EOM Pharmaceuticals (IMUC) News Today

$0.20
0.00 (0.00%)
(As of 03:29 PM ET)
SourceHeadline
MarketBeat logoEOM Pharmaceuticals (OTCMKTS:IMUC) Shares Up 17.3%
americanbankingnews.com - April 19 at 2:22 AM
uk.finance.yahoo.com logoImmunoCellular Therapeutics, Ltd. (IMUC)
uk.finance.yahoo.com - January 5 at 8:19 PM
wsj.com logoEOM Pharmaceutical Holdings Inc.
wsj.com - December 29 at 10:23 PM
finance.yahoo.com logoEOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
finance.yahoo.com - November 7 at 8:25 AM
markets.businessinsider.com logoIZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years
markets.businessinsider.com - November 4 at 2:51 PM
msn.com logoImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues
msn.com - November 3 at 1:43 PM
morningstar.com logoOramed Pharmaceuticals Inc ORMP
morningstar.com - November 1 at 5:45 PM
markets.businessinsider.com logoAnalyst Ratings for Olema Pharmaceuticals
markets.businessinsider.com - October 11 at 1:29 PM
finance.yahoo.com logoEOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
finance.yahoo.com - September 6 at 8:29 AM
uk.finance.yahoo.com logoQ2 2023 PAVmed Inc Earnings Call
uk.finance.yahoo.com - August 17 at 4:17 AM
msn.com logoEOM Pharmaceuticals shelves plans to uplist shares, raise $15M
msn.com - August 3 at 6:53 PM
benzinga.com logoAcumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
benzinga.com - July 17 at 7:33 PM
marketwatch.com logoAmneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient
marketwatch.com - July 3 at 6:05 PM
marketwatch.com logoAmneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment
marketwatch.com - June 14 at 1:04 PM
msn.com logoTrade commission fights Amgen's $28B purchase of Horizon Therapeutics
msn.com - May 16 at 4:38 PM
msn.com logoPharma CEOs to testify in U.S. Senate hearing on insulin prices
msn.com - May 10 at 5:12 PM
marketwatch.com logo8-K: Acumen Pharmaceuticals, Inc.
marketwatch.com - May 10 at 12:09 PM
msn.com logoOlema Pharmaceuticals GAAP EPS of -$0.70 misses by $0.04
msn.com - May 9 at 9:07 PM
investing.com logoOliX Pharmaceuticals Inc (226950)
investing.com - May 9 at 4:07 PM
msn.com logoUSFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drug
msn.com - March 30 at 8:43 AM
reuters.com logoU.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
reuters.com - March 27 at 3:53 PM
marketwatch.com logoRegeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains
marketwatch.com - March 13 at 6:22 PM
finance.yahoo.com logoEOM Pharmaceuticals Holdings, Inc. (IMUC)
finance.yahoo.com - March 11 at 8:01 AM
seekingalpha.com logoIonis Pharmaceuticals, Inc. (IONS) Q4 2022 Earnings Call Transcript
seekingalpha.com - February 24 at 9:16 AM
technews.tmcnet.com logoAltruBio Hosting Research & Development Update on Immune Checkpoint Enhancer Platform for T Cell Mediated Immunological Diseases
technews.tmcnet.com - December 8 at 8:41 AM
marketwatch.com logoAlaunos Therapeutics Shares Drop 24% After Public Offering Prices
marketwatch.com - November 29 at 10:39 AM
marketwatch.com logoInVivo Therapeutics Adds to Surge After Hours, Recently at $10.85
marketwatch.com - October 6 at 10:46 PM
benzinga.com logoImunon Appoints James E. Dentzer to its Board of Directors
benzinga.com - October 3 at 8:40 PM
morningstar.com logoSeres Therapeutics Inc MCRB Stock Quote
morningstar.com - September 21 at 4:36 PM
benzinga.com logoImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Guggenheim Nantucket Therapeutics Conference
benzinga.com - September 14 at 8:27 PM
reuters.com logoImmunoCellular Therapeutics Ltd
reuters.com - September 11 at 10:14 PM
seekingalpha.com logoEOM Pharmaceutical Files For $25 Million IPO Uplisting To Nasdaq
seekingalpha.com - June 28 at 2:46 AM
seekingalpha.com logoEOM Pharmaceuticals files to uplist to Nasdaq
seekingalpha.com - June 24 at 6:28 PM
finance.yahoo.com logoEOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
finance.yahoo.com - December 2 at 9:50 AM
Get EOM Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMUC and its competitors with MarketBeat's FREE daily newsletter.

The Next Step of Their Control Is Here … (Ad)

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

IMUC Media Mentions By Week

IMUC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMUC
News Sentiment

-0.16

0.32

Average
Medical
News Sentiment

IMUC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMUC Articles
This Week

1

0

IMUC Articles
Average Week

Get EOM Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMUC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:IMUC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners